Phosphate Binders in CKD: ‟New Kids on the Block”
DOI:
https://doi.org/10.53778/pjkd31089Anahtar Kelimeler:
hyperphosphatemia- mineral bone disease- sevelamer- ferric sitrate- lanthanum- sucro ferricoxyhydroxideÖz
Phosphate control is essential component of dietary and medical management of chronic kidney disease (CKD) patients. Hyperphosphatemia has a significant effect on morbidity and mortality of CKD patients. This review takes us through the different older and newer medications available for management of hyperphosphatemia.
İndir
Yayınlanmış
Sayı
Bölüm
Lisans
Telif Hakkı (c) 2021 Muhammad Umair Afzal, Shafeeq Cheema

Bu çalışma Creative Commons Attribution-NonCommercial 4.0 International License ile lisanslanmıştır.
